The CEO will present findings from Edesa’s late-stage study of EB05, being evaluated as a treatment for Acute Respiratory ...

HONOLULU -- As suspected, patients with acute respiratory distress syndrome (ARDS) had particularly bad outcomes if they had coexisting pulmonary hypertension (PH), an analysis of the National ...

I would like your opinion on the role of corticosteroids in early and late ARDS. When should I institute steroids in my patient with ARDS? The complexities of the ARDSnet study and the variation seen ...

Breathing troubles can feel frightening, especially when the cause is serious. Among the many lung conditions, two names that often come up are pneumonia and Acute Respiratory Distress Syndrome (ARDS) ...

Inhaled sedation with sevoflurane in patients with moderate to severe acute respiratory distress syndrome (ARDS) resulted in fewer ventilator-free days at 28 days and lower 90-day survival than ...

Inhaled sevoflurane significantly reduced ventilator-free days and 90-day survival versus IV propofol in moderate to severe ARDS. Inhaled volatile sedatives grew in popularity for prolonged use in ...

The incidence of ARDS in patients with severe acute pancreatitis is about 36%, with age (older than 50 years) and female sex as key risk factors.

Please provide your email address to receive an email when new articles are posted on . Pulmonary hypertension plus acute respiratory distress syndrome resulted in poor hospital outcomes. Odds for ...

Drawing from research on sepsis and complement biology, they developed the monoclonal antibody vilobelimab to block overactive inflammatory responses in patients with severe inflammatory diseases ...